A new Memorial Sloan-Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.

Dr. Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.

Dr. Morrow, Chief of Memorial Sloan-Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.

Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.

Dr. Morrow is the first surgeon and the first person from Memorial Sloan-Kettering to receive the American Society of Clinical Oncology’s award, which recognizes breast cancer researchers who are also excellent mentors.

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.